RIGL

RIGL Operating Expenses

$165.90MTTM · USD

Period ending:

RIGL FY Operating ExpensesUSD
RIGL FY Operating Expenses1999-12-31: $22.97M2000-12-31: $46.28M2001-12-31: $40.26M2002-12-31: $52.80M2003-12-31: $51.88M2004-12-31: $61.60M2005-12-31: $63.30M2006-12-31: $76.52M2007-12-31: $92.13M2008-12-31: $135.29M2009-12-31: $111.65M2010-12-31: $89.68M2011-12-31: $91.12M2012-12-31: $101.63M2013-12-31: $96.62M2014-12-31: $99.50M2015-12-31: $80.64M2016-12-31: $90.12M2017-12-31: $84.10M2018-12-31: $116.91M2019-12-31: $127.47M2020-12-31: $136.70M2021-12-31: $160.65M2022-12-31: $174.04M2023-12-31: $130.26M2024-12-31: $136.44M2025-12-31: $149.20M$174.04M$0.00
1999-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

RIGL operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 27 observations from Dec 31, 1999 to Dec 31, 2025.

Rigel Pharmaceuticals Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
149,195,000
136,439,000
130,263,000
174,043,000
160,649,000
136,699,000
127,473,000
116,905,000
84,100,000
90,124,000
80,638,000
99,499,000
96,619,000
101,627,000
91,118,000
89,683,000
111,646,000
135,289,000
92,127,000
76,520,000
63,298,000
61,600,000
51,882,000
52,804,000
40,263,000
46,280,000
22,970,000

Compare operating expenses

All RIGL financial metrics · RIGL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.